IGAN

Clinical trials for IGAN explained in plain language.

Never miss a new study

Get alerted when new IGAN trials appear

Sign up with your email to follow new studies for IGAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 1

Promising kidney drug trial halted early – what it means for patients

Disease control Terminated

This study tested an experimental drug called ALXN2050 in adults with kidney inflammation caused by lupus (lupus nephritis) or IgA nephropathy. The goal was to see if the drug could reduce protein in the urine, a sign of kidney damage. The trial was stopped early, so results are …

Matched conditions: IGAN

Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Apr 29, 2026 09:48 UTC

IGAN

Get alerted when new IGAN trials appear

Promising kidney drug trial halted early – what it means for patients